Edition:
United Kingdom

Ritter Pharmaceuticals Inc (RTTR.OQ)

RTTR.OQ on NASDAQ Stock Exchange Capital Market

0.61USD
15 Feb 2019
Change (% chg)

$-0.01 (-2.42%)
Prev Close
$0.62
Open
$0.65
Day's High
$0.68
Day's Low
$0.60
Volume
147,949
Avg. Vol
40,429
52-wk High
$3.99
52-wk Low
$0.47

Chart for

About

Ritter Pharmaceuticals, Inc. develops therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. The Company's segment is focusing on the development and commercialization of RP-G28. The Company conducts human gut health research by exploring metabolic capacity of the gut microbiota and... (more)

Overall

Beta: --
Market Cap(Mil.): $5.57
Shares Outstanding(Mil.): 14.76
Dividend: --
Yield (%): --

Financials

  RTTR.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -1.44 -- --
ROI: -264.95 8.92 14.45
ROE: -264.95 10.08 15.96

Earnings vs. Estimates